Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial page now displays the study record for pembrolizumab after stem cell transplantation, including its eligibility requirements, treatment arms, measured outcomes, locations, and publications. The record is marked completed and no longer recruiting.
    Difference
    57%
    Check dated 2026-11-10T19:50:07.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T20:16:41.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    An NIH notice about its terminology transition appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:43:22.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:54:04.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The Study Record page now displays a 403 Forbidden error, and the error page includes a minimal header and a Home link, indicating that access to the record is blocked.
    Difference
    19%
    Check dated 2026-09-22T23:09:40.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.6.6 to v3.7.0, indicating an updated version in the site metadata.
    Difference
    0.1%
    Check dated 2026-09-15T21:44:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.